The announcement of a Virtual R&D Day focusing on new development strategies for Plinabulin and updates on Seed Therapeutics is likely to generate positive investor sentiment. This is because such events often serve as platforms for companies to showcase progress, innovation, and future plans, which can be critical in attracting investment and partnerships. The focus on cancer treatment, a high-interest area in biotech, further enhances the potential positive impact on BeyondSpring's stock.